Plasma β-Amyloid, Tau Protein, and Gut Microbiota Alterations in Mild  Cognitive Impairment and Alzheimer’s Disease, A comparative analysis of  anti- amyloid therapy

Muhammad Ali, Sheikh Muhammad Junaid Ur Rehman, Abdul Aleem, Nida Ayesha, Farah Asad, Rafiq Ahmed Siddiqui

Plasma β-Amyloid, Tau Protein, and Gut Microbiota Alterations in Mild Cognitive Impairment and Alzheimer’s Disease, A comparative analysis of anti- amyloid therapy

Authors

Muhammad Ali, Sheikh Muhammad Junaid Ur Rehman, Abdul Aleem, Nida Ayesha, Farah Asad, Rafiq Ahmed Siddiqui

Keywords:

B-Amyloid, Tau protein, Gut microbiota

Abstract

The progressive accumulation of-bamyloid and tau pathology is central tocognitive decline, yet peripheral biomarkersand gut microbiota alterations remaininsufficiently integrated into therapeuticresponse evaluation.

References

Kablak-Ziembicka A, Przewlocki T. Clinical significance of carotid intima-media complex and carotid plaque assessment by ultrasound for the prediction of adverse cardiovascular events in primary and secondary care patients. J Clin Med. 2021;10(20):4628. DOI:10.3390/jcm10204628.

Downloads

Published

2025-12-29

How to Cite

Muhammad Ali, Sheikh Muhammad Junaid Ur Rehman, Abdul Aleem, Nida Ayesha, Farah Asad, Rafiq Ahmed Siddiqui. (2025). Plasma β-Amyloid, Tau Protein, and Gut Microbiota Alterations in Mild Cognitive Impairment and Alzheimer’s Disease, A comparative analysis of anti- amyloid therapy. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 4123–4128. Retrieved from https://ijprt.org/index.php/pub/article/view/1380